These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37042639)

  • 1. Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank.
    Tseng WH; Huang HW; Li CC; Chang CS; Chan WP; Lin KP; Wu CH
    Ann Clin Transl Neurol; 2023 May; 10(5):779-786. PubMed ID: 37042639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
    Louwsma J; Brunger AF; Bijzet J; Kroesen BJ; Roeloffzen WWH; Bischof A; Kuhle J; Drost G; Lange F; Kuks JBM; Gans ROB; Hazenberg BPC; Nienhuis HLA
    Amyloid; 2021 Mar; 28(1):50-55. PubMed ID: 32883119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATTRv amyloidosis Italian Registry: clinical and epidemiological data.
    Russo M; Obici L; Bartolomei I; Cappelli F; Luigetti M; Fenu S; Cavallaro T; Chiappini MG; Gemelli C; Pradotto LG; Manganelli F; Leonardi L; My F; Sampaolo S; Briani C; Gentile L; Stancanelli C; Di Buduo E; Pacciolla P; Salvi F; Casagrande S; Bisogni G; Calabrese D; Vanoli F; Di Iorio G; Antonini G; Santoro L; Mauro A; Grandis M; Di Girolamo M; Fabrizi GM; Pareyson D; Sabatelli M; Perfetto F; Rapezzi C; Merlini G; Mazzeo A; Vita G
    Amyloid; 2020 Dec; 27(4):259-265. PubMed ID: 32696671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.
    Pinto MV; Pinto LF; Dias M; Rosa RS; Mundayat R; Pedrosa RC; Waddington-Cruz M
    J Neurol Sci; 2019 Aug; 403():1-6. PubMed ID: 31163298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
    Ungerer MN; Hund E; Purrucker JC; Huber L; Kimmich C; Aus dem Siepen F; Hein S; Kristen AV; Hinderhofer K; Kollmer J; Schönland S; Hegenbart U; Weiler M
    Amyloid; 2021 Jun; 28(2):91-99. PubMed ID: 33283548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
    Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
    BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of hereditary transthyretin amyloidosis in the northernmost region of Sweden: a retrospective cohort study.
    Mejia Baranda J; Ljungberg J; Wixner J; Anan I; Oskarsson V
    Amyloid; 2022 Jun; 29(2):120-127. PubMed ID: 35023433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features.
    Pozsonyi Z; Peskó G; Takács H; Csuka D; Nagy V; Szilágyi Á; Hategan L; Muk B; Csányi B; Nyolczas N; Dézsi L; Molnár JM; Csillik A; Révész K; Iványi B; Szabó F; Birtalan K; Masszi T; Arányi Z; Sepp R
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.
    Maestro-Benedicto A; Vela P; de Frutos F; Mora N; Pomares A; Gonzalez-Vioque E; Briceño A; Cabrera E; Cobo-Marcos M; Dominguez F; Gonzalez-Lopez E; Segovia J; Lara-Pezzi E; Garcia-Pavia P
    Eur J Heart Fail; 2022 Dec; 24(12):2367-2373. PubMed ID: 35999650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series.
    Waddington-Cruz M; Schmidt H; Botteman MF; Carter JA; Stewart M; Hopps M; Fallet S; Amass L
    Orphanet J Rare Dis; 2019 Feb; 14(1):34. PubMed ID: 30736835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.
    Pasutharnchat N; Taychargumpoo C; Vorasettakarnkij Y; Amornvit J
    BMC Neurol; 2021 May; 21(1):206. PubMed ID: 34022837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.
    Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K
    Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Transthyretin Amyloidosis- Clinical and Genetic Characteristics of a Multiracial South-East Asian Cohort in Singapore.
    Chen Z; Koh JS; Saini M; Tay KSS; Jayne Tan Y; Chai JYH; Fam SR; Juraidah AR; Lim PK; Ng ASL; Prasad K; Tan CB; Umapathi T; Verma KK; Yong MH; Yu C; Ng PS
    J Neuromuscul Dis; 2021; 8(4):723-733. PubMed ID: 34024775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
    Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
    Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays.
    Kaku MC; Bhadola S; Berk JL; Sanchorawala V; Connors LH; Lau KHV
    Amyloid; 2022 Sep; 29(3):184-189. PubMed ID: 35253562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary transthyretin amyloidosis: A multifaceted disease].
    Breu MS; Grimm A; Winter N
    MMW Fortschr Med; 2023 Feb; 165(Suppl 1):32-33. PubMed ID: 36849771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country.
    Luigetti M; Guglielmino V; Antonini G; Casali C; Ceccanti M; Chiappini MG; De Giglio L; Di Lazzaro V; Di Muzio A; Goglia M; Inghilleri M; Leonardi L; Massa R; Pennisi EM; Petrucci A; Proietti E; Rispoli M; Sabatelli M; Di Girolamo M
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant transthyretin amyloidosis (ATTRv) polyneuropathy in Greece: a broad overview with a focus on non-endemic unexplored regions of the country.
    Koutsis G; Kastritis E; Kontogeorgiou Z; Kartanou C; Kokotis P; Rentzos M; Breza M; Kleopa KA; Christodoulou K; Oikonomou E; Anastasakis A; Angelidakis P; Sarmas I; Kargiotis O; Tzagournissakis M; Zaganas I; Foukarakis E; Sachpekidis V; Papathoma A; Panas M; Stefanis L; Dimopoulos MA; Karadima G
    Neuromuscul Disord; 2021 Dec; 31(12):1251-1258. PubMed ID: 34740514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuropathy in hereditary transthyretin amyloidosis: A narrative review.
    Tozza S; Severi D; Spina E; Iovino A; Aruta F; Ruggiero L; Dubbioso R; Iodice R; Nolano M; Manganelli F
    J Peripher Nerv Syst; 2021 Jun; 26(2):155-159. PubMed ID: 33960565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.
    Inês M; Coelho T; Conceição I; Ferreira L; de Carvalho M; Costa J
    Orphanet J Rare Dis; 2020 Mar; 15(1):67. PubMed ID: 32143656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.